You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
While the overall number of oncologists who ordered the company's tests in the third quarter did not change, the frequency with which they reordered fell by about 7 percent.
The GeneReader NGS system, which is geared toward clinical laboratories, is an integrated package with multiple components that cover all steps to analyze a tissue sample.
AmoyDx will develop and commercialize a series of oncology tests that use Illumina NGS technology, including the firm's TruSight Tumor 15 panel.
Under the terms of the agreement, N-of-One will provide clinical interpretation services for samples sequenced on a 50-gene hot-spot solid tumor panel.
The firm is conducting a multi-center prospective clinical study to validate its liquid biopsy ctDNA test, which it plans to launch for pharma customers this year and commercially in 2016.
Gene panel testing of cancer patients helps clinicians identify actionable mutations, according to presenters at this year's AACC meeting.
EDGC will have exclusive distribution rights in South Korea for the OncoDEEP Dx panel and other technologies, while physicians there will be able to access the OncoShare web platform.
Last month, the company presented results from a pilot study at the Worldwide Innovative Networking (WIN) Symposium in Paris.
Deck: The panels, which cover lung, colon, brain, and thyroid cancer as well as melanoma and gastrointestinal stromal tumors, target newly diagnosed patients.
So far, results from the MSK-IMPACT test have been reported for more than 4,500 patients.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.